Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

download Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

of 62

Transcript of Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    1/62

    The Implementation

    of DESFLURANE

    Dr. Alisher Agzamov MD PhD

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    2/62

    DESFLURANE

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    3/62

    Desflurane for LMA removal

    in anaesthetised adults Makkar JK, Arora S, Jain K, Wig J; ED50

    of desflurane for laryngeal maskairway removal in anaesthetised

    adults;Anaesthesia (Jul 2011)

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    4/62

    Desflurane for LMA removal

    in anaesthetised adults

    The end-tidal concentration ranged

    from 2.1% to 5.3%. of DS allows

    removal of the LMA in 50% ofanaesthetised adults (ED50);

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    5/62

    Desflurane for LMA removal

    in anaesthetised adults

    32 female patients;

    Aged: 30-50 years;

    Undergoing intracavity caesium

    implants for cervical carcinoma under

    GA.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    6/62

    Desflurane for LMA removal inanaesthetised adults

    Anaesthesia was induced with

    Propofol 2-3 mg/kg;

    And maintained with DS in a 50% N2O-

    O2 mixture.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    7/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    8/62

    Desflurane for LMA removal inanaesthetised adults

    At the end of surgery, a predetermined

    target end-tidal DS concentration

    (starting at 4%) was maintained for 10min using Dixon's up-down method

    and the LMA was removed.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    9/62

    Desflurane for LMA removal inanaesthetised adults

    The target end-tidal concentration in

    the next patient was increased ordecreased by 0.5% depending upon

    the response of the previous patient.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    10/62

    DESFLURANE Removal of the LMA without coughing,

    clenching, biting, movement or any

    adverse airway event during or within1 min after removal was considered to

    be successful.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    11/62

    DESFLURANE The LMA successfully removed in 50%

    (ED50) and 95% (ED95) of the

    anaesthetised adults at end-tidal DSconcentrations of:

    2.4% (95% CI 1.3-2.9) and

    3.8% (3.1-9.6).

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    12/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    13/62

    Desflurane & Sevoflurane

    Apuhan T, Yildirim YS, Aksoy F, Borin O,

    Ozturan O; The effects of desflurane

    and sevoflurane on the peri- andpostoperative bleeding of

    adenotonsillectomy patients;

    International Journal of PediatricOtorhinolaryngology (Mar 2011)

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    14/62

    Desflurane & Sevoflurane It has been compared the effects of

    volatile anesthetics, Desflurane and

    Sevoflurane on intra-operative andpostoperative bleeding in patients who

    underwent tonsillectomy and

    adenoidectomy.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    15/62

    Desflurane & Sevoflurane 400 children (190 girl and 210 boys);

    Aged between 2 and 16 years;

    Were included in this clinical trial.

    The patients underwent conventional

    cold tonsillectomy and curettageadenoidectomy under GA.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    16/62

    Desflurane & Sevoflurane For the maintenance of anaesthesia,

    the patients were randomized into two

    groups: DS group and

    SV group, Each groups including 200 patients.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    17/62

    Desflurane & Sevoflurane DS concentration: 4% and 6% (0.7-0.9

    MAC);

    Whereas SV concentration: 2% and2.5% (0.7-0.9 MAC).

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    18/62

    Desflurane & Sevoflurane The amount of perioperative bleeding

    in milliliters was measured by usingseparate aspirator bags for each

    patient.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    19/62

    Desflurane & Sevoflurane DS caused significantly lower amount

    of perioperative bleeding compared toSV (p=0.03).

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    20/62

    Desflurane & Sevoflurane No significant difference was

    observed between the two groups in

    terms of age, body mass index andoperation duration, respectively

    (p=0.20, p=0.49, p=0.07).

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    21/62

    Desflurane & Sevoflurane DS leads to a lower amount of

    intraoperative bleeding than SV duringtonsillectomy and adenoidectomy

    operations.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    22/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    23/62

    The Ad Hoc Introduction of

    Desflurane Eberhart LH, Gerlach H, Knaber R, KochT, Morin AM, Rhr F, Wagner S, Wulf H,

    Zoremba M; Implementation of newstandards in anaesthesia : Exemplified

    by the ad hoc introduction of

    desflurane in 10 German hospitals;Der Anaesthesist (Nov 2010)

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    24/62

    The Ad Hoc Introduction of Desflurane According to numerous

    pharmacoeconomic studies new

    anaesthesia techniques can improverecovery times;

    And thus can have a positive

    economic impact on patient turnover.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    25/62

    The Ad Hoc Introduction of Desflurane However, artificial study protocols do

    not always match real world situations

    and thus the practical impact of suchstudies remains unclear.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    26/62

    The Ad Hoc Introduction of Desflurane At 10 hospitals exclusively using SV as a

    volatile anaesthetic, the ad hoc implementation

    of DS was studied with respect to post-

    anaesthetic recovery times (primary endpoint);

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    27/62

    The Ad Hoc Introduction of Desflurane And postoperative outcome measured by the

    Quality of Recovery Score- (QoR-)40, on the first

    postoperative day was investigated.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    28/62

    The Ad Hoc Introduction of Desflurane Patients undergoing elective surgical

    procedures under GA with:

    Sevoflurane (n=186) or

    Desflurane (n=176)

    was started immediately after a period of a few

    days after introducing the new drug to all

    patients.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    29/62

    The Ad Hoc Introduction of Desflurane

    Except for the volatile anaesthetic the

    anaesthetic procedure was performedaccording to local standing operating

    procedures.

    Ad H I t d ti f

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    30/62

    Ad Hoc Introduction of

    Desflurane

    All parameters indicating the

    immediate postanaesthetic recoverywere superior in the patients receiving

    DS (mean SD).

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    31/62

    The Ad Hoc Introduction of Desflurane Time to extubation was accelerated

    from:

    8.79.7 min.to

    6.26.8 min.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    32/62

    The Ad Hoc Introduction of Desflurane Times to recalling name and date of

    birth were accelerated by:

    2.6 min, and 3.8 min, respectively.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    33/62

    The Ad Hoc Introduction of Desflurane Transferring the patients from the OT

    to the PARU was:

    17.311.5 min after SV and 13.77.8 min after anaesthesia with

    DS.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    34/62

    The Ad Hoc Introduction of Desflurane Eligibility for discharge according to a

    modified Aldrete score was reached

    after: 10398 and

    7976 min, respectively.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    35/62

    The Ad Hoc Introduction of Desflurane

    The postoperative recovery (QoR 40

    questionnaire) did not differ 24 h later.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    36/62

    The Ad Hoc Introduction of Desflurane The implementation of a new drug (DS

    to substitute SV) can improve speed of

    recovery immediately after terminationof anaesthesia even after a very short

    period of introducing the new

    technique but has no positive longterm effects.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    37/62

    The Ad Hoc Introduction of Desflurane The results of this trial performed

    under a real world scenario (health

    service research) without tightstandardization by an artificial study

    protocol supports the results

    originating from randomizedcontrolled clinical trials.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    38/62

    The effects of LF and HF IA N2O and DS on

    mucociliary activity and pulmonary function tests

    Bilgi M, Goksu S, Mizrak A, Cevik C, GulR, Koruk S, Sahin L; Comparison of the

    effects of low-flow and high-flowinhalational anaesthesia with nitrousoxide and desflurane on mucociliary

    activity and pulmonary function tests;European Journal of Anaesthesiology(Nov 2010)

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    39/62

    The effects of LF and HF IA N2O and DS

    on mucociliary activity and pulmonary

    function tests

    It has been investigated the effects of

    inhalational anaesthesia using lowand high gas flow rates of N2O and DS

    on mucociliary clearance and

    pulmonary function.

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    40/62

    The effects of LF and HF IA N2O and DSon mucociliary activity and pulmonary

    function tests

    50 patients, ASA physical status I-II,

    Age: 18 - 70 years.

    Patients were assigned randomly toone of two study groups.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    41/62

    Desflurane

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    42/62

    Desflurane

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    43/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    44/62

    Desflurane

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    45/62

    The effects of LF and HF IA N2O and DSon mucociliary activity and pulmonary

    function tests

    The fresh gas flow rate was 1 L/min

    (0.5 L/min O2 + 0.5 L/min N2O + DS) in

    group 1 and;

    3 L/min (1.5 L/min O2 + 1.5 L/min N2O+ DS) in group 2.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    46/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    47/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    48/62

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    49/62

    The effects of LF and HF IA N2O and DSon mucociliary activity and pulmonary

    function tests

    Patients' haemodynamic parameters

    and changes in the humidity and

    temperature of the inspired gaseswere recorded and the saccharin

    clearance time was measured before

    and after anaesthesia.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    50/62

    Desflurane

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    51/62

    The effects of LF and HF IA N2O and DSon mucociliary activity and pulmonary

    function tests

    Respiratory parameters

    Body Temperature

    ETCO2 concentration and

    Inspired and Expired O2 and

    N2O concentrations were alsorecorded.

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    52/62

    Desflurane

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    53/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    54/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    55/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    56/62

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    57/62

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    58/62

    The effects of LF and HF IA N2O and DSon mucociliary activity and pulmonary

    function tests

    The FVC and FEV in 1 s were

    significantly lower and the saccharinclearance time was significantly

    longer in group 2 compared to group 1

    (P

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    59/62

    e e ects o a d O a d Son mucociliary activity and pulmonary

    function tests

    There were statistically significant

    differences between the groups

    regarding the humidity andtemperature of the inspired gases

    (P

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    60/62

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    61/62

    on mucociliary activity and pulmonary

    function tests

    Respiratory function and mucociliary

    clearance are better preserved in a

    low-flow anaesthesia technique thanin high-flow anaesthesia with N2O and

    DS.

    The effects of LF and HF IA N2O and DS

  • 7/29/2019 Desfluranetheimplementation - Dr. a. Alisher Ppt 15.08.2011

    62/62

    on mucociliary activity and pulmonary

    function tests

    A low-flow anaesthesia technique with

    N2O and DS provide an importantclinical advantage because it provides

    appropriately heated and humidified

    gases to the tracheobronchial tree.